Article
Thymidylate synthetase allelic imbalance in clear cell renal carcinoma.
Cancer chemotherapy and pharmacology - 1 Nov 2009
Colavito Davide, Cartei Giuseppe, Dal Bianco Massimo, Stecca Anna, Zustovich Fable, Dalle Carbonare Maurizio, Ragazzi Eugenio, Farina Miriam, Colombrino Eva, Leon Alberta
Abstract excerpt
PURPOSE: To investigate the allelic status of the thymidylate synthetase (TYMS) gene, located at chromosome band 18p11.32, in renal cell carcinoma (RCC). TYMS is a key target of the 5-fluorouracil (5-FU)-based class of drugs, frequently considered in combination therapies in advanced RCC. TYMS variants, such as the TYMS polymorphic 5'-untranslated region variable number tandem repeat sequence (VNTR), are under...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
